GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford Cannabinoid Technologies Holdings PLC (FRA:0CB) » Definitions » Net Cash per Share
中文

Oxford Cannabinoid Technologies Holdings (FRA:0CB) Net Cash per Share

: €0.00 (As of Oct. 2023)
View and export this data going back to 2021. Start your Free Trial

Net Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities minus Total Liabilities minus Minority Interest and then divided by Shares Outstanding (EOP). Oxford Cannabinoid Technologies Holdings's Net Cash per Share for the quarter that ended in Oct. 2023 was €0.00.

The historical rank and industry rank for Oxford Cannabinoid Technologies Holdings's Net Cash per Share or its related term are showing as below:

During the past 5 years, the highest Price-to-Net-Cash Ratio of Oxford Cannabinoid Technologies Holdings was 4.00. The lowest was 2.38. And the median was 3.19.

FRA:0CB's Price-to-Net-Cash is not ranked *
in the Biotechnology industry.
Industry Median: 3.825
* Ranked among companies with meaningful Price-to-Net-Cash only.

Oxford Cannabinoid Technologies Holdings Net Cash per Share Historical Data

The historical data trend for Oxford Cannabinoid Technologies Holdings's Net Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford Cannabinoid Technologies Holdings Annual Data
Trend May18 May19 May20 May21 Apr23
Net Cash per Share
- - - 0.02 -

Oxford Cannabinoid Technologies Holdings Semi-Annual Data
May19 Nov19 May20 Nov20 May21 Nov21 Oct22 Apr23 Oct23
Net Cash per Share Get a 7-Day Free Trial Premium Member Only 0.02 0.01 - - -

Competitive Comparison

For the Biotechnology subindustry, Oxford Cannabinoid Technologies Holdings's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oxford Cannabinoid Technologies Holdings Price-to-Net-Cash Distribution

For the Biotechnology industry and Healthcare sector, Oxford Cannabinoid Technologies Holdings's Price-to-Net-Cash distribution charts can be found below:

* The bar in red indicates where Oxford Cannabinoid Technologies Holdings's Price-to-Net-Cash falls into.



Oxford Cannabinoid Technologies Holdings Net Cash per Share Calculation

In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.

Oxford Cannabinoid Technologies Holdings's Net Cash per Share for the fiscal year that ended in Apr. 2023 is calculated as

Net Cash per Share (A: Apr. 2023 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(2.609-0.663-0)/960.416
=0.00

Oxford Cannabinoid Technologies Holdings's Net Cash per Share for the quarter that ended in Oct. 2023 is calculated as

Net Cash per Share (Q: Oct. 2023 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(1.308-0.969-0)/960.416
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Oxford Cannabinoid Technologies Holdings  (FRA:0CB) Net Cash per Share Explanation

Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.


Oxford Cannabinoid Technologies Holdings Net Cash per Share Related Terms

Thank you for viewing the detailed overview of Oxford Cannabinoid Technologies Holdings's Net Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Oxford Cannabinoid Technologies Holdings (FRA:0CB) Business Description

Traded in Other Exchanges
Address
267 Banbury Road, Prama House, Oxford, GBR, OX2 7HT
Oxford Cannabinoid Technologies Holdings PLC is a pharmaceutical company engaged in cannabinoid drug development. The company uses a drug development that includes proprietary cannabinoid derivatives, natural phytocannabinoids (pCBs), and in-licensed compounds. Its primary market focus is the pain market, and OCT initially aims to develop a portfolio of four drug candidates for approval as licensed pain medicines.

Oxford Cannabinoid Technologies Holdings (FRA:0CB) Headlines

No Headlines